CSPC Pharmaceutical Group Limited

OTCPK:CHJT.F Stock Report

Market Cap: US$13.3b

CSPC Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CHJT.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Dec 25BuyUS$7,629,939Dongchen CaiIndividual6,706,000US$1.14
22 Dec 25BuyUS$14,174,112Dongchen CaiIndividual13,454,000US$1.05
28 Nov 25SellUS$204,612Dongchen CaiIndividual540,000US$0.38
25 Nov 25BuyUS$10,320,940Dongchen CaiIndividual10,300,000US$1.00
24 Nov 25BuyUS$14,253,446Dongchen CaiIndividual14,866,000US$0.96
21 Nov 25BuyUS$28,433,490Dongchen CaiIndividual30,000,000US$0.95
17 Oct 25BuyUS$3,402,525Dongchen CaiIndividual3,000,000US$1.13
09 Oct 25BuyUS$2,424,022Dongchen CaiIndividual2,000,000US$1.21
06 Oct 25BuyUS$2,478,806Dongchen CaiIndividual2,000,000US$1.24
03 Oct 25BuyUS$1,551,059Dongchen CaiIndividual1,254,000US$1.24
02 Oct 25BuyUS$7,430,412Dongchen CaiIndividual6,000,000US$1.24
02 Sep 25BuyUS$69,634Xin CaiIndividual50,000US$1.39
01 Sep 25BuyUS$68,236Xin CaiIndividual50,000US$1.36
15 Jul 25SellUS$14,762,512Dongchen CaiIndividual39,283,000US$0.38
23 Jun 25SellUS$6,859,469UBS Asset Management AGCompany7,082,000US$0.97
25 Apr 25BuyUS$3,523,905Dongchen CaiIndividual4,500,000US$0.78
24 Apr 25BuyUS$4,525,122Dongchen CaiIndividual5,780,000US$0.78
09 Apr 25BuyUS$604,814Dongchen CaiIndividual1,000,000US$0.60
08 Apr 25BuyUS$1,448,220Dongchen CaiIndividual2,350,000US$0.62
07 Apr 25BuyUS$4,124,815Dongchen CaiIndividual6,700,000US$0.62

Insider Trading Volume

Insider Buying: CHJT.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CHJT.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies755,676,3136.61%
Individual Insiders2,906,074,67025.4%
Institutions3,327,055,81729.1%
General Public4,444,218,13238.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.3%
Dongchen Cai
2,890,024,670US$3.4b0%no data
6.37%
Common Success International Limited
728,796,313US$847.8m0%no data
4.64%
BlackRock, Inc.
530,338,510US$616.9m0.13%0.01%
3.27%
UBS Asset Management AG
373,988,291US$435.0m0%0.04%
3.12%
The Vanguard Group, Inc.
356,542,338US$414.7m0.51%0.01%
1.79%
Norges Bank Investment Management
204,853,086US$238.3m200%0.02%
1.36%
Dimensional Fund Advisors LP
155,215,585US$180.6m0.01%0.02%
1.23%
GF Fund Management Co., Ltd.
140,168,000US$163.1m0%0.39%
1.08%
Hang Seng Investment Management Limited
123,863,334US$144.1m4.21%0.47%
0.78%
China Universal Asset Management Company Ltd.
89,404,800US$104.0m0%0.47%
0.73%
Schroder Investment Management (Hong Kong) Ltd.
84,026,000US$97.7m-5.2%0.52%
0.64%
Harvest Fund Management Co. Ltd.
73,670,040US$85.7m0%0.14%
0.64%
Geode Capital Management, LLC
73,262,155US$85.2m1.43%no data
0.64%
China Southern Asset Management Co., Ltd.
73,199,440US$85.2m0%0.18%
0.55%
Bosera Asset Management Co., Ltd.
62,344,000US$72.5m0%0.59%
0.51%
First Sentier Investors (Australia) IM Ltd
57,840,614US$67.3m0%0.21%
0.49%
E Fund Management Co., Ltd.
55,467,183US$64.5m0.27%0.07%
0.46%
CSOP Asset Management Limited
52,104,112US$60.6m5.88%0.47%
0.44%
China Asset Management Co. Ltd.
50,445,442US$58.7m54.8%0.08%
0.43%
American Century Investment Management Inc
48,918,960US$56.9m7.17%0.02%
0.39%
Eastspring Investments (Singapore) Limited
44,510,000US$51.8m0%0.19%
0.37%
Aberdeen Group Plc
42,037,137US$48.9m0%0.03%
0.25%
State Street Global Advisors, Inc.
28,951,660US$33.7m-3.91%no data
0.25%
Amundi Asset Management SAS
28,933,174US$33.7m0%0.01%
0.24%
Massive Top Limited
26,880,000US$31.3m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/06 10:54
End of Day Share Price 2026/02/20 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 57 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rebecca LiangBernstein
Shan HeBernstein
Ethan CuiBofA Global Research